Search

The article addresses the question of whether the use of the skin-lightener drug hydroquinone is safe for the skin. Although hydroquinone is said to be effective in treating skin hyperpigmentation, some organizations have found that it could cause dermatitis and onchronosis, and it may also have potential mutagenic properties. The U.S. Food and Drug Administration has yet to pass regulations on the use of hydroquinone as of March 2009, but pharmaceutical and cosmetic companies are reportedly at work to produce safer skin-lightening agents.

The article presents information about active ingredients included in skin-lightening products. In the U.S., hydroquinone is considered as the gold standard when it comes to skin lightening although it has been the center of controversies. Another agent for skin lightening is mequinol which is combined with tretinoin and vitamin C. Other agents for skin lightening are licorice extract and alpha lipoic acid.

The article reports on the result of the study conducted by Obagi Medical Products Inc. which evaluates hydroquinone and L-Ascorbic acid-based system in the treatment of photodamaged skin in the U.S. It mentions that results have shown that the treatment system for normal to oily skin helps ameliorate early signs of photodamage. It affirms that 100% of patients find it good and excellent as compared to other treatments.

The article reports on the proposal of the U.S. Food and Drug Administration (FDA) to ban hydroquinone-containing products by the end of 2006. In line with this, the agency states that skin bleaching products are not generally recognized as safe and effective and are misbranded. Furthermore, over-the-counter and prescription which are hydroquinone-containing products will be banned following the establishment of the rule on product safety.

The article reports on the new rule proposed by the Food and Drug Administration (FDA) that would classify over-the-counter skin-bleaching products as not as safe and effective, which could pose to an increased risk of cancer in the U.S. The proposal would ban all prescriptions hydroquinone products that have not gone through the FDA's new drug application process. However, the proposal could affect more than 200 products that contain hydroquinone in strengths from 0.4% to 5%.

The article offers information on the result of the clinical study conducted by Obagi Medical Products Inc. which sows that the combination of hydroquinone skin care system and tretinoin may decrease melasma severity in patients with darker skin in the U.S. It indicates that melasma is a disorder that can cause emotional distress. It affirms that patients reported that reduction in pigment discoloration has decreased their self-consiousness by 60% and unattractiveness by 45%.

Provides information on skin toxicity/percutaneous absorption testing using in vivo and in vitro methodology. Skin patch testing of chemicals/products on normal `healthy' skin; Studies on octamethylcyclotetrasiloxane; Hydroquinone; More information.

The article suggests some cosmetics that are safe and effective for treating skin discoloration. It cites the move by the U.S. Food and Drug Administration to ban the use of hydroquinone in cosmetics due to possible links to a condition that darkens and thickens the skin. It mentions the move by some cosmetic companies to develop skin care products that are formulated with safer alternatives. It lists some cosmetic ingredients that are safe and effective for treating skin discoloration including kojic acid, arbutin, hyaluronic acid and vitamin C.

The article focuses on the health issues related to hydroquinone-based lightening creams, which over-the-counter sale was banned by the U.S. Food and Drug Administration after reports that linked the drug to exogenous ochronosis.

The author reflects on the difficulty in finding the right health products to treat one's illness. She stresses that she had to dig her reading glasses and examine the fine print of decongestants because each brand came in multiple versions. She asserts the need to ask for two types of nonprescription drugs that are kept behind the counter. She emphasizes that some over-the-counter skin-lightening products that contain hydroquinone are prohibited by the U.S. Food and Drug Administration.

The article offers news briefs in relation to cosmetic products. The Evian Affinity Holiday Skin Moisturizer is a gradual self-tanner for the face, which is made with pure Evian water. The U.S. Food and Drug Administration has proposed that over-the-counter products with skin-bleaching ingredient hydroquinone should be officially categorized as a drug only available by prescription. The Black Orchid Eau de Parfum is made of a rare black-orchid note that is fused with black truffle, black currant, patchouli and vetiver.

The article focuses on the formulation of new mechanisms to treat excessive pigmentation following the proposal of the U.S. Food and Drug Administration to ban hydroquinone as an over-the-counter product. It reports that the topical agent lignin peroxidase, Syneron, may be used as an adjunct to hydroquinone since it is able to break down melanin which is responsible for hyperpigmentation. Also examined for their therapeutic uses are azelaic acid, licorice extract, and kojic acid.

The article offers information on the effectiveness of hydroquinone in treating skin pigmentations. It notes that the U.S. Food and Drug Administration (FDA) is still reviewing comments on the controversial debate pertaining to hydroquinone carcinogenicity. It states that hydroquinione is combined with floucinolone acetonide and tretinoin known as Tri-luma (Galderma), a triple-combination cream used to treat melasma. However, hydroquinone and Tri-Luma received different approval from FDA.

The article focuses on the proposed bill passed by the U.S. Food and Drug Administration to regulate the dosage of hydroquinone in skin cancer treatment. The bill is based on the controversial issue of murine leukemia models which link to the products with exogenous ochronosis. Several researchers have studied on botanicals and other agents as alternative treatment for treating skin pigmentation.

The article focuses on the study of facial hyperpigmentation in the U.S. It mentions that the two products which are developed for treating facial hyperpigmentation in women with skin of color were compared head-to-head in a 12-week, randomized, double-blind clinical trial. Moreover, similar improvements were achieved at all follow-ups in multiple assessments among women using hydroquinone-based products.

The article discusses the banned of selling skin bleaching creams containing hydroquinone as proposed by the U.S. Food and Drug Administration. Views from dermatologist Susan Taylor, regarding the ban is offered. It has been stated that several requirements are needed to be complied by the product manufacturers for the continuance sale of their products, which are labeled as new products. In response, concerned dermatologist prepare their comments to push the reconsideration of the new rule.

Presents a study on the effectiveness of combined formulas containing hydroquinone and retinoid in treatment of melasma and postinflammtory hyperpigmentation according to research from the Hawai. Identification of side effect measure than lightening agents containing a corticosteroid; Effects of hyperpigmentation in change of skin color due to increased melanin content and larger and larger melanosome; Impact of hyperpigmentation disorders on the psychosocial implications with patients suffering embarrassment, low self-esteem and depression.

Focuses on the importance of considering ethnic variations in formulating skin-care products in the United States. Need for specifically formulated skin products; Comparison between ethnic and Caucasian skin; Legality of hydroquinone as a skin lightener; Parameters of black and white skin; Emphasis on the delivery of active treatment products.

Reports on the increase in hydroquinone prices in 1998 in response to the tightened and steadily growing markets in the United States. Percentage price increase announced by key producer, Rhodia Inc.; Reason for the increase in prices; Other companies that have increased their prices; Primary applications for hydroquinone.

The article presents a brief history of the development of hydroquinone which is commonly used as a skin product for bleaching as well as the discussion of side effects and its acceptance from the U.S. Food and Drug Administration (FDA).

The article presents questions and answers related to dermatology. One question focuses on what best sunscreen can used following photodynamic therapy. Another question was raised on why the U.S. Food and Drug Administration (FDA) has proposed the removal of hydroquinone from the over-the-counter market.

The article reports on the concern over the safety of skin lightening products that use the ingredient hydroquinone. The United States Food and Drug Administration's ban on hydroquinone has sparked concern between the product that consumers use to remove age spots on their skin and the safety issues raised.

The article offers views from various dermatologist in the U.S. regarding the Food and Drug Administration's proposed ban of over-the-counter hydroquinone products. It has been stated that the inclusion of hydroquinone in cosmetics has been banned in Great Britain since 2001. However, dermatologists in the U.S. wonders on the administration's real basis of banning the hydroquinone. Information of each of the dermatologist as wells as their comments on the issue is presented.

The article reports on the move of the U.S. Food and Drug Administration to ban overcountering skin lightening products that contain hydroquinone. One reason in implementing the ban is the research study in rats which found out the possibility of hydroquinone to trigger cancer. Another problem dermatologists see with the hydroquinone is a skin disease called ochronosis.

Presents news briefs on detergents industry in the United States. Appointment of Sateesh B. Lele as senior vice president and chief information officer of Avon Products Inc.; Applications of hydroquinone USP offered by Charkit Chemical Corp.; Focus of the research and development center to be developed by Nu Skin Enterprises Inc. at Stanford University.